Baird Positive on Amicus Therapeutics (FOLD) Following Pre-Announcement
Tweet Send to a Friend
Baird analyst Michael Ulz reiterated an Outperform rating and $20.00 price target on Amicus Therapeutics (NASDAQ: FOLD) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
